文献速递消化内镜消化道肿瘤与早癌

热敏异戊烷气化用于动物模型内镜切除中的黏膜抬举(附视频)

Thermo-sensitive isopentane aerification for mucosal lift during endoscopic resection in animal models (with video).
PubMed 文献 · Gastrointest Endosc · 2017-03-10

研究在猪胃体外和鼠体内比较热敏异戊烷与生理盐水作为黏膜下注射剂的抬举性能。异戊烷沸点27.8°C,体温下气化可支撑黏膜抬举。结果显示异戊烷用量更少、抬举维持更久、黏膜下剥离更快,组织学未见组织损伤。

要点

  • 异戊烷沸点27.8°C,体温下气化产生支撑,实现黏膜抬举。
  • 体外猪胃中,异戊烷达到最大抬举高度所需体积为生理盐水的2%。
  • 大鼠模型中同剂量异戊烷抬举效果优于生理盐水,组织学未见组织损伤。

核心结论

  • 异戊烷作为黏膜下注射剂的可行性、有效性和安全性已得到证实,热敏气化可能是有助于内镜黏膜下剥离的有前景方法。

研究设计与样本

  • 体外研究使用猪胃,以37°C水浴模拟体温,比较异戊烷与生理盐水的抬举性能、抬举强度维持时间、辅助黏膜下剥离效果及黏膜下组织变化。
  • 体内研究使用大鼠,进一步比较异戊烷与生理盐水的抬举效果、病理影响和安全性。

主要发现

  • 体外研究中,与生理盐水相比,异戊烷达到最大抬举高度所需体积为生理盐水的2%。
  • 体外研究中,异戊烷抬举维持时间更长,黏膜下剥离操作更快。
  • 气化导致黏膜下结缔组织空泡化,有助于内镜黏膜切除术和术后恢复。
  • 大鼠模型中,相同剂量下异戊烷产生的黏膜抬举和范围均优于生理盐水。
  • 组织学检查显示,应用异戊烷未见组织损伤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Mucosal lift is critical for successful endoscopic treatment. Normal saline (NS) solution is widely used as the submucosal filler, but its short persistency restricts clinical endoscopic submucosal dissection (ESD). In this study, thermo-sensitive isopentane was introduced for submucosal injection. With a boiling point at 27.8°C, liquid isopentane can be easily applied, and gasification inflation can provide great support for submucosal lifting at body temperature. The feasibility and efficiency of isopentane were evaluated in this study. METHODS: Porcine stomachs were used for in vitro evaluation. A 37°C water bath was used to mimic body temperature. Compared with NS, isopentane was studied for its lifting performance, including injection dosage, persistence of lifting strength, and efficacy for assisting submucosal dissection. The changes in submucosal tissue were also compared. For in vivo evaluation, rats were used to further compare the differences between isopentane and NS, including lifting efficacy, pathologic effect, and safety. RESULTS: Compared with NS, the maximum lifting height was achieved with less isopentane (2% NS volume). Longer persistency and faster operation for submucosal dissection were also recorded for isopentane during the in vitro study. Aerification resulted in vacuolization of submucosal connective tissue, which facilitates EMR and postoperative recovery. The same results were confirmed in the rat model. With the same dosage, isopentane produced better mucosal elevation and larger range than NS. According to the histologic examination, no tissue injury was observed with isopentane application. CONCLUSIONS: As a submucosal injection agent, the feasibility, efficacy, and safety of isopentane has been demonstrated. Thermo-sensitive aerification may be a promising approach to facilitate ESD.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Liu W, Wang M, Zhao L, et al. Thermo-sensitive isopentane aerification for mucosal lift during endoscopic resection in animal models (with video). Gastrointest Endosc. 2017. PMID: 28288842. doi:10.1016/j.gie.2017.02.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。